We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Bosch Healthcare Presents Vivalytic Point-of-Care PCR System

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: For the first time, Bosch is organizing a panel discussion with Vivalytic (Photo courtesy of Bosch Healthcare)
Image: For the first time, Bosch is organizing a panel discussion with Vivalytic (Photo courtesy of Bosch Healthcare)

Bosch Healthcare Solutions (Waiblingen, Germany) is present at this year’s MEDICA to showcase new tests and its universal platform for molecular diagnostics at the point of care. The MEDICA is an annual international trade fair for the medical industry. At the trade fair, exhibitors from all over the world present their latest products, services, and technologies in the fields of medicine, health care, and nursing. MEDICA is an important platform for the exchange of knowledge and experience between professionals in the industry, including doctors, nurses, medical technicians, and healthcare managers. In addition to the exhibition, various forums and conferences are held each year, where experts from different areas of the medical industry give presentations and lead discussions. These forums provide a great opportunity for professionals to learn about the latest trends and developments in their respective fields and to exchange ideas with other experts.

This year, for the first time and exclusively, Bosch Healthcare Solutions is organizing a panel discussion with Vivalytic, and to discuss the topic of laboratory diagnostics at the point of care with experts from various industries. Particular importance will be given to point-of-care PCR systems, such as Vivalytic, which provide rapid test results at the point of sample collection and are easy and intuitive to operate. This exclusive event will provide new insights into the "Third Pillar" of diagnostics. The panelists are proven experts in their field and will be sharing some experiential insights on the topic. Visitors can also attend the round table discussion to learn more about the innovative Vivalytic system and the challenges of the diagnostics sector at the point of care.

Related Links:
Bosch Healthcare Solutions

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Researchers have found a way to spot the debilitating disease Alzheimer\'s before it develops into dementia (Photo courtesy of 123RF)

Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia

Alzheimer’s disease is well known for its slow development over many years, which typically leads to treatment interventions only after the disease has advanced to stages where it may be nearly impossible... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)

Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections

Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.